Cite
APA Citation
Nanni, P., De Giovanni, C., Burocchi, A., Nicoletti, G., Landuzzi, L., Palladini, A., Ianzano, M. L., Arioli, I., Colombo, M. P., & Lollini, P. (2018). oX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis. Oncoimmunology, 7, . http://access.bl.uk/ark:/81055/vdc_100068019142.0x000009